Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will cure the sick. But a virus’ main goal is to replicate and infect, so the virus can mutate to survive and continue on its journey. Looking at the coronavirus, you’ll see it has several mutations, including the most recently talked about delta variant sweeping over India and invading the rest of the globe.
This delta variant is about 4 times more transmissible and also more severe than the original Wuhan strain or the A-lineage. And Pfizer (NYSE: PFE), Moderna (NASDAQ: MRNA) and Johnson & Johnson (NYSE: JNJ) have come out to proclaim their respective vaccines’ effectiveness against this and other variants that cause COVID-19. In fact, real world scenarios in India show the effectiveness of the vaccines around 65% effective as opposed to the presumed 95%. That’s a significant decrease. But no matter the percentage rate effectiveness of the vaccines, the only way to win the battles to come is to develop effective therapeutics to complement the them.
Variants Now and to Come
The first strain of the coronavirus coming out of Wuhan is known as the A-lineage. Since the beginning, this highly variable RNA virus mutated to enhance its effectiveness at infecting the population, thereby creating the B-lineage, which includes everything from D614G to the current delta version.
Now, in Peru, medical professionals identified the start of a new lineage — C. That lineage includes the Lambda variant, which could be more deadly than the previous variants of SARS-CoV-2, although the evidence to support that is insufficient at this time. That said, there is no way to stop the virus from mutating again and again into more deadly strains.
So, NanoViricides (NYSE: NNVC), a global leader in nanomedicine, decided to work on medicines to treat and heal the disease — no matter the mutation. And the drug already showed its oral effectiveness in animal models. It is moving as fast as possible to keep up with the prolific virus to get society to a point where it can live with something that looks like it’s here to stay. In addition to NanoViricides, other drugs are in the works to continue the fight against the coronavirus and its variants. These include Merck’s molnupiravir, which received several billion dollars in government funding and failed Phase 2 of clinical studies, and Pfizer’s oral antiviral protease inhibitor PF-07321332/ritonavir combination soon expected to enter Phase 2 clinical trials.
After the Pandemic’s end
The truth is, people are waiting for the pandemic to end, but SARS-CoV-2 and its variants will more than likely become endemic as it keeps coming back in more mutated versions for the foreseeable future. As UK Prime Minister Boris Johnson points out, the population will have to “learn to live with” it.
Because of the social and economic impact the virus has had, it’s unreasonable to think the entire world will continue to shut down indefinitely. As a global society, that’s not a sustainable existence. The better idea is to use vaccinations to limit the spread while developing therapeutics to treat the COVID-19 disease caused by the virus. That way, people can coexist with the coronavirus and get back to the kind of life society so desperately craves.
As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult. Now, scientists at UT Southwestern have developed nanoparticles that can break [...]
In an article recently published in the journal Talanta, researchers demonstrated a new approach to enable the specific detection of biomarkers in human tear by employing an aptamer-based graphene affinity nanosensor. The ability to detect [...]
Selenium (Se) is an essential element found in aquatic feeds that promotes the proper development, wellbeing, and fitness of marine animals. Selenium can be transformed into nanomaterials that are more easily accessible, absorbed, and consumed by [...]
In an article recently published in the journal Nanotechnology, researchers employed a single particle imaging method for fluorescence excitation with moderate intensity to achieve spatial resolution. Here, the semiconductor nanocrystals were accessed, whose emission lifetimes [...]
Grinding is an essential manufacturing process, yet the heat due to friction associated with the process causes damage to the part being processed. Lubrication is used to reduce friction; however, traditional petroleum-based lubricants can [...]
A team of researchers from HSE University, Skoltech, MPGU, and MISIS have developed a nanophotonic-microfluidic sensor whose potential applications include cancer detection, monitoring and treatment response assessment. Today, the device can identify gases and [...]
Researchers have made a scientific breakthrough with the development of ‘nanomachines’ that can kill cancerous cells. The research team headed by Dr Youngdo Jeong from the Center for Advanced Biomolecular Recognition at the Korea Institute of Science and Technology (KIST) has engineered [...]
A novel freeze-dissolving approach has been devised that offers greater efficiency and sustainability compared to the classic freeze-drying process to make superfine powder or nanoparticles. In the research published in the journal ACS Sustainable Chemistry & Engineering, sphere-shaped [...]
Participants wanted for study on the regulation of what future AI-driven nanomedicines should look like
Would you like to help in some research on the regulation of what future AI-driven nanomedicines should look like? If so, researchers at the University of Bristol are looking for volunteers to discuss ethical [...]
In an article recently published in the journal Applied Surface Science, the researchers synthesized green fluorescent carbon dots (G-CDs) from 3,5-diaminobenzoic acid and citric acid. The as-prepared G-CDs were used to target the nucleolus and [...]
Doxorubicin (DOX) is a powerful anti-cancer medication, and efforts have been made to design nanostructures for delivering it to cancerous cells. The nanostructures increase the cytotoxic effects of DOX on cancerous cells, while reducing the negative effects [...]
A team of Brown University researchers has developed a new responsive material that is able to release encapsulated cargo only when pathogenic bacteria are present. The material could be used to make wound dressings [...]
Novel three-drug regimen used to manage life-threatening developments. In April 2021, a 42-year-old man reached out to Brian Hill, MD, PhD, for a second opinion after being diagnosed with hairy cell leukemia following a bone [...]
When the virus hunters landed in the remote African village of Yambuku in 1976, the nuns warned them to stay back. The sisters had cordoned off the area where they were caring for people [...]